Jean-Luc Bodmer

Title: Innovations in Vaccines by Jean-Luc Bodmer

Introduction

Jean-Luc Bodmer is a notable inventor based in Concord, MA (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines against clostridium difficile. His work focuses on creating recombinant toxins that can provide protection against infections caused by this bacterium.

Latest Patents

Jean-Luc Bodmer holds a patent for "Vaccines against clostridium difficile comprising recombinant toxins." This invention relates to recombinant toxin A (TcdA) and toxin B (TcdB), as well as binary toxin A (CDTa) proteins that have been specifically mutated to reduce or eliminate toxicity. The patent also covers vaccines and immunogenic compositions that include these recombinant toxins, along with methods for inducing an immune response through their administration. The exemplary embodiments of this invention utilize a baculovirus/insect cell expression system to express the mutant toxins.

Career Highlights

Bodmer is associated with Merck Sharp & Dohme Corp., where he continues to advance research in vaccine development. His innovative approach to recombinant toxins has the potential to significantly impact public health by providing effective immunization against clostridium difficile infections.

Collaborations

Throughout his career, Jean-Luc Bodmer has collaborated with esteemed colleagues such as Jon Henry Heinrichs and Susan Lynn Secore. These partnerships have fostered a collaborative environment that enhances the research and development of new vaccine technologies.

Conclusion

Jean-Luc Bodmer's contributions to vaccine innovation demonstrate the importance of research in combating infectious diseases. His patented work on recombinant toxins is a significant step forward in the field of immunology.